Draft:William Greenleaf: Difference between revisions

This is a draft Articles for creation (AfC) submission. It is not currently pending review. While there are no deadlines, abandoned drafts may be deleted after six months. To edit the draft click on the “Edit” tab at the top of the window. To be accepted, a draft should: It is strongly discouraged to write about yourself, your business or employer. If you do so, you must declare it. Where to get help If you need help editing or submitting your draft, please ask us a question at the AfC Help Desk or get live help from experienced editors. These venues are only for help with editing and the submission process, not to get reviews. If you need feedback on your draft, or if the review is taking a lot of time, you can try asking for help on the talk page of a relevant WikiProject. Some WikiProjects are more active than others so a speedy reply is not guaranteed. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags.

American scientist

William J. Greenleaf (born December 24, 1979) is an American molecular biologist, biophysicist, and inventor who is a professor of genetics at the Stanford University School of Medicine. His research focuses on high-throughput sequencing and optical microscopy methods for studying gene regulation and chromatin structure. Greenleaf is a co-inventor of ATAC-seq, a widely-used epigenomic method developed by his lab.

Biography

attended Mayo High School, worked at Mayo Clinic on ultrasound-mediated gene transfection and was 1998 finalist in the Westinghouse Science Talent Search
Greenleaf’s PhD was funded by the NSF
studied at Cambridge via Gates Cambridge Scholarship
Greenleaf was named a CZ Biohub investigator and Arc Institute innovation investigator. ATAC-seq used for personalized medicine.
Greenleaf was a scientific co-founder of Epinomics, which was acquired by 10x Genomics in 2018. He has also served as scientific advisor to biotech companies operating in areas related to high-throughput sequencing and precision medicine, including Guardant Health, Quantapore, and Ultima Genomics.

References

External links

Category:Living people
Category:Stanford University School of Medicine faculty
Category:American geneticists